Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haifa Shen

Showing results (101-110 of 122) with videos related to

Pageof 13
Sort By:
Molecular Pharmaceutics|March 15, 2018
DNA Thioaptamer with Homing Specificity to Lymphoma Bone Marrow InvolvementJunhua Mai, Xin Li, Guodong Zhang, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 6, 2024
An inoculation site-retained mRNA vaccine induces robust immune responses against SARS-CoV-2 variantsLei Huang, Fanfan Zhao, Muye He, et al.
Theranostics|January 2, 2018
A Novel DNA Aptamer for Dual Targeting of Polymorphonuclear Myeloid-derived Suppressor Cells and Tumor CellsHaoran Liu, Junhua Mai, Jianliang Shen, et al.
Plos Computational Biology|June 11, 2016
Theory and Experimental Validation of a Spatio-temporal Model of Chemotherapy Transport to Enhance Tumor Cell KillZhihui Wang, Romica Kerketta, Yao-Li Chuang, et al.
Cell Reports|May 5, 2015
Porous silicon microparticle potentiates anti-tumor immunity by enhancing cross-presentation and inducing type I interferon responseXiaojun Xia, Junhua Mai, Rong Xu, et al.
Nature Biotechnology|March 15, 2016
An injectable nanoparticle generator enhances delivery of cancer therapeuticsRong Xu, Guodong Zhang, Junhua Mai, et al.
Haematologica|July 6, 2014
The Sox4/Tcf7l1 axis promotes progression of BCR-ABL-positive acute lymphoblastic leukemiaHaiqing Ma, Saradhi Mallampati, Yue Lu, et al.
Ebiomedicine|August 1, 2022
Corrigendum to "PTGER3 induces ovary tumorigenesis and confers resistance to cisplatin therapy through up-regulation Ras-MAPK/Erk-ETS1-ELK1/CFTR1 axis" [EBioMedicine 40 (2019) 290-304]Cristian Rodriguez-Aguayo, Emine Bayraktar, Cristina Ivan, et al.
Ebiomedicine|January 19, 2019
PTGER3 induces ovary tumorigenesis and confers resistance to cisplatin therapy through up-regulation Ras-MAPK/Erk-ETS1-ELK1/CFTR1 axisCristian Rodriguez-Aguayo, Emine Bayraktar, Cristina Ivan, et al.
Pharmaceutics|June 21, 2020
Liposome-Embedding Silicon Microparticle for Oxaliplatin Delivery in Tumor ChemotherapyArmando Cevenini, Christian Celia, Stefania Orrù, et al.
Pageof 13

Showing results (101-110 of 122) with videos related to

Sort By:
Pageof 13
Molecular Pharmaceutics|March 15, 2018
DNA Thioaptamer with Homing Specificity to Lymphoma Bone Marrow InvolvementJunhua Mai, Xin Li, Guodong Zhang, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 6, 2024
An inoculation site-retained mRNA vaccine induces robust immune responses against SARS-CoV-2 variantsLei Huang, Fanfan Zhao, Muye He, et al.
Theranostics|January 2, 2018
A Novel DNA Aptamer for Dual Targeting of Polymorphonuclear Myeloid-derived Suppressor Cells and Tumor CellsHaoran Liu, Junhua Mai, Jianliang Shen, et al.
Plos Computational Biology|June 11, 2016
Theory and Experimental Validation of a Spatio-temporal Model of Chemotherapy Transport to Enhance Tumor Cell KillZhihui Wang, Romica Kerketta, Yao-Li Chuang, et al.
Cell Reports|May 5, 2015
Porous silicon microparticle potentiates anti-tumor immunity by enhancing cross-presentation and inducing type I interferon responseXiaojun Xia, Junhua Mai, Rong Xu, et al.
Nature Biotechnology|March 15, 2016
An injectable nanoparticle generator enhances delivery of cancer therapeuticsRong Xu, Guodong Zhang, Junhua Mai, et al.
Haematologica|July 6, 2014
The Sox4/Tcf7l1 axis promotes progression of BCR-ABL-positive acute lymphoblastic leukemiaHaiqing Ma, Saradhi Mallampati, Yue Lu, et al.
Ebiomedicine|August 1, 2022
Corrigendum to "PTGER3 induces ovary tumorigenesis and confers resistance to cisplatin therapy through up-regulation Ras-MAPK/Erk-ETS1-ELK1/CFTR1 axis" [EBioMedicine 40 (2019) 290-304]Cristian Rodriguez-Aguayo, Emine Bayraktar, Cristina Ivan, et al.
Ebiomedicine|January 19, 2019
PTGER3 induces ovary tumorigenesis and confers resistance to cisplatin therapy through up-regulation Ras-MAPK/Erk-ETS1-ELK1/CFTR1 axisCristian Rodriguez-Aguayo, Emine Bayraktar, Cristina Ivan, et al.
Pharmaceutics|June 21, 2020
Liposome-Embedding Silicon Microparticle for Oxaliplatin Delivery in Tumor ChemotherapyArmando Cevenini, Christian Celia, Stefania Orrù, et al.
Pageof 13